SKP2
S-phase kinase-associated protein 2
Also known as: FBL1, FBXL1, p45, SKP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13309
- Gene
- SKP2
- Ensembl
- ENSG00000145604
- Chromosome
- 5
- Canonical length
- 424 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
OverviewNCBI Gene
This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbls class; in addition to an F-box, this protein contains 10 tandem leucine-rich repeats. This protein is an essential element of the cyclin A-CDK2 S-phase kinase. It specifically recognizes phosphorylated cyclin-dependent kinase inhibitor 1B (CDKN1B, also referred to as p27 or KIP1) predominantly in S phase and interacts with S-phase kinase-associated protein 1 (SKP1 or p19). In addition, this gene is established as a protooncogene causally involved in the pathogenesis of lymphomas. Alternative splicing of this gene generates three transcript variants encoding different isoforms. [provided by RefSeq, Jul 2011]
Canonical amino-acid sequenceUniProt
424 residues, UniProt reviewed canonical sequence.
>Q13309|SKP2
1 MHRKHLQEIP DLSSNVATSF TWGWDSSKTS ELLSGMGVSA LEKEEPDSEN IPQELLSNLG
61 HPESPPRKRL KSKGSDKDFV IVRRPKLNRE NFPGVSWDSL PDELLLGIFS CLCLPELLKV
121 SGVCKRWYRL ASDESLWQTL DLTGKNLHPD VTGRLLSQGV IAFRCPRSFM DQPLAEHFSP
181 FRVQHMDLSN SVIEVSTLHG ILSQCSKLQN LSLEGLRLSD PIVNTLAKNS NLVRLNLSGC
241 SGFSEFALQT LLSSCSRLDE LNLSWCFDFT EKHVQVAVAH VSETITQLNL SGYRKNLQKS
301 DLSTLVRRCP NLVHLDLSDS VMLKNDCFQE FFQLNYLQHL SLSRCYDIIP ETLLELGEIP
361 TLKTLQVFGI VPDGTLQLLK EALPHLQINC SHFTTIARPT IGNKKNQEIW GIKCRLTLQK
421 PSCLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SKP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 36 nTPM
Expression across tissuesHPA
Tissue
- placenta: 36 nTPM
- thymus: 12 nTPM
- bone marrow: 11 nTPM
- liver: 11 nTPM
- tonsil: 7.7 nTPM
- esophagus: 7.5 nTPM
Single-cell type
- extravillous trophoblasts: 278 nCPM
- migrating cytotrophoblasts: 236 nCPM
- hepatocytes: 193 nCPM
- cytotrophoblasts: 177 nCPM
- syncytiotrophoblasts: 74 nCPM
- erythrocyte progenitors: 57 nCPM
Immune cell
- myeloid DC: 14 nTPM
- eosinophil: 14 nTPM
- basophil: 9.2 nTPM
- MAIT T-cell: 6.8 nTPM
- classical monocyte: 6.6 nTPM
- naive CD4 T-cell: 6.4 nTPM
Brain region
- white matter: 13 nTPM
- cerebral cortex: 11 nTPM
- cerebellum: 11 nTPM
- spinal cord: 10 nTPM
- medulla oblongata: 10 nTPM
- basal ganglia: 9.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 1.95
- DepMap mean gene effect
- -0.65
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to cell-matrix adhesion
- defense response to virus
- G1/S transition of mitotic cell cycle
- G2/M transition of mitotic cell cycle
- innate immune response
- positive regulation of double-strand break repair via homologous recombination
- positive regulation of intracellular estrogen receptor signaling pathway
- positive regulation of protein polyubiquitination
- positive regulation of smooth muscle cell proliferation
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein K48-linked ubiquitination
- protein K63-linked ubiquitination
- regulation of apoptotic process
- regulation of cell cycle
- SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SKP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SKP2 as an antibody target. Whether an autoantibody or antibody against SKP2 could matter depends on whether native SKP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SKP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SKP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...